D-0432-2023 Class II Terminated

Recalled by The Harvard Drug Group — La Vergne, TN

Recall Details

Product Type
Drugs
Report Date
March 8, 2023
Initiation Date
February 23, 2023
Termination Date
April 30, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,586 cartons

Product Description

Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4

Reason for Recall

Packaging defect: observed packaging defect, blister packaging inadequately sealed.

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Lot: M04145 Exp. 01/2024